Green Planet Bio Engineering Co. Ltd.

GPLB · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
92
SEC Filings

Business Summary

Green Planet Bioengineering Co., Ltd. operates as a public reorganized shell corporation seeking to acquire or merge with an existing business operation. Originally incorporated as Mondo Acquisition II, Inc. in Delaware in 2006, the company previously operated in the agritech sector in China through Elevated Throne Overseas Ltd., which was divested in 2010. It currently has no active business operations.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGPLBdiscussed_in_filing Blockchain & Crypto
topic_mentionGPLBdiscussed_in_filing Capital Expenditure
topic_mentionGPLBdiscussed_in_filing Regulation
topic_mentionGPLBdiscussed_in_filing Blockchain & Crypto
topic_mentionGPLBdiscussed_in_filing Capital Expenditure
topic_mentionGPLBdiscussed_in_filing Regulation
topic_mentionGPLBdiscussed_in_filing Blockchain & Crypto
topic_mentionGPLBdiscussed_in_filing Capital Expenditure
topic_mentionGPLBdiscussed_in_filing Regulation
topic_mentionGPLBdiscussed_in_filing Blockchain & Crypto
topic_mentionGPLBdiscussed_in_filing Capital Expenditure
topic_mentionGPLBdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001654954-26-003081EDGAR10K words
2025-03-072024-12-310001654954-25-002462EDGAR
2024-03-292023-12-310001654954-24-003942EDGAR
2023-03-302022-12-310001654954-23-003905EDGAR
2022-03-142021-12-310001654954-22-003076EDGAR
2021-03-312020-12-310001654954-21-003636EDGAR
2020-03-112019-12-310001654954-20-002496EDGAR
2019-03-012018-12-310001654954-19-002154EDGAR
2018-03-082017-12-310001654954-18-002291EDGAR
2017-03-102016-12-310001654954-17-001883EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001654954-25-013033EDGAR6K words
2025-08-082025-06-300001654954-25-009248EDGAR
2025-05-152025-03-310001654954-25-005701EDGAR
2024-11-142024-09-300001654954-24-014376EDGAR
2024-08-142024-06-300001654954-24-010544EDGAR
2024-05-092024-03-310001654954-24-005844EDGAR
2023-11-092023-09-300001654954-23-014026EDGAR
2023-08-102023-06-300001654954-23-010437EDGAR
2023-05-122023-03-310001654954-23-006318EDGAR
2022-11-142022-09-300001654954-22-015258EDGAR
2022-08-092022-06-300001654954-22-010856EDGAR
2022-05-132022-03-310001654954-22-006705EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-05-150001654954-25-005637EDGAR1K words
2022-10-140001654954-22-013777EDGAR
2019-12-230001654954-19-014171EDGAR
2012-04-230001354488-12-001977EDGAR
2012-03-230001354488-12-001311EDGAR
2011-11-220001354488-11-004719EDGAR
2011-02-040001354488-11-000350EDGAR
2010-04-190001188112-10-001003EDGAR
2010-01-250001188112-10-000118EDGAR
2009-09-020001471242-09-000006EDGAR

92 total filings indexed. 60 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

shell-corporation-/-merger-and-acquisition agritech-(former)

Company Identity

CIK0001392449
TickerGPLB
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: db4aa91bdb9dd5ca9ef6929c5741ef06dfee9109c2fe2a75984280e2d648bd15
parent: e53a20cb96bd2a00d0e070963c407822efbb13e9ca732bc7b426011c78110c17
content hash: 4497a95ed8071c6f51f2c57651d30391d124e6489a227c5c0565f90490fad30d
signed: 2026-04-13T04:45:21.277Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf